Director, Oncology Key Account & Regional Marketing

United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, Medical Devices, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's degree in Life Sciences, with an MBA or Ph.D. being preferred. A minimum of 10 years of experience in product marketing, field sales, or market analytics within the medical diagnostics, biotech, pharmaceutical, or related industries is required. Prior background in oncology and/or genomics is strongly preferred, and experience with oncology GPO liaison is highly desirable. Demonstrated strategic agility, strong executive presence, effective collaboration skills, a customer-centric focus, and the ability to communicate complex concepts simply are essential.

Responsibilities

The Director will develop and drive key account and regional marketing initiatives for Natera's oncology portfolio, focusing on independent oncology networks, GPOs, MSOs, and IDNs. This role involves leading a team of Regional Marketing Managers to execute regional marketing strategies, enhance market penetration, and engage healthcare providers. Responsibilities include defining value propositions for key account partnerships, developing tailored account-based marketing plans, monitoring product performance, managing marketing collateral for key accounts, and presenting strategies and outcomes to executive leadership.

Skills

Oncology Marketing

Key Account Management

Regional Marketing

Marketing Strategy

Product Marketing

Sales Enablement

Market Penetration

Cross-functional Collaboration

Team Leadership

Marketing Collateral Development

Value Proposition Development

Performance Monitoring

Healthcare Provider Engagement

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free